In Vitro and In Vivo Efficacy of Tecovirimat against a Recently Emerged 2022 Monkeypox Virus Isolate

The authors tested the efficacy of TPOXX both in vitro and in vivo against a clade 2 Canadian 2022 isolate of monkeypox virus isolated during the current outbreak.